|
1.
|
Sugihara E and Saya H: Complexity of
cancer stem cells. Int J Cancer. 132:1249–1259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J,
Konda B, Black KL and Yu JS: Antigen-specific T-cell response from
dendritic cell vaccination using cancer stem-like cell-associated
antigens. Stem Cells. 27:1734–1740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Wong DJ, Liu H, Ridky TW, Cassarino D,
Segal E and Chang HY: Module map of stem cell genes guides creation
of epithelial cancer stem cells. Cell Stem Cell. 2:333–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Muller FJ, Laurent LC, Kostka D, Ulitsky
I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH,
Schmidt NO and Loring JF: Regulatory networks define phenotypic
classes of human stem cell lines. Nature. 455:401–405. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
Gifford DK, Melton DA, Jaenisch R and Young RA: Core
transcriptional regulatory circuitry in human embryonic stem cells.
Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Gure AO, Stockert E, Scanlan MJ, Keresztes
RS, Jager D, Altorki NK, Old LJ and Chen YT: Serological
identification of embryonic neural proteins as highly immunogenic
tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA.
97:4198–4203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Spisek R, Kukreja A, Chen LC, Matthews P,
Mazumder A, Vesole D, Jagannath S, Zebroski HA, Simpson AJ, Ritter
G, Durie B, Crowley J, Shaughnessy JD Jr, Scanlan MJ, Gure AO,
Barlogie B and Dhodapkar MV: Frequent and specific immunity to the
embryonal stem cell-associated antigen SOX2 in patients with
monoclonal gammopathy. J Exp Med. 204:831–840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Schmitz M, Temme A, Senner V, Ebner R,
Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK,
Fussel M, Bachmann M, Rieber EP and Weigle B: Identification of
SOX2 as a novel glioma-associated antigen and potential target for
T cell-based immunotherapy. Br J Cancer. 96:1293–1301. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Laga AC, Lai CY, Zhan Q, Huang SJ,
Velazquez EF, Yang Q, Hsu MY and Murphy GF: Expression of the
embryonic stem cell transcription factor SOX2 in human skin:
relevance to melanocyte and merkel cell biology. Am J Pathol.
176:903–913. 2010. View Article : Google Scholar
|
|
11.
|
Zhang X, Yu H, Yang Y, Zhu R, Bai J, Peng
Z, He Y, Chen L, Chen W, Fang D, Bian X and Wang R: SOX2 in gastric
carcinoma, but not Hath1, is related to patients’
clinicopathological features and prognosis. J Gastrointest Surg.
14:1220–1226. 2010.PubMed/NCBI
|
|
12.
|
Lengerke C, Fehm T, Kurth R, Neubauer H,
Scheble V, Muller F, Schneider F, Petersen K, Wallwiener D, Kanz L,
Fend F, Perner S, Bareiss PM and Staebler A: Expression of the
embryonic stem cell marker SOX2 in early-stage breast carcinoma.
BMC Cancer. 11:422011. View Article : Google Scholar
|
|
13.
|
Bass AJ, Watanabe H, Mermel CH, Yu S,
Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I,
Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O’Kelly M, Dutt A,
Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue
CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin
L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS,
Cecconello I, Jr UR, Marie SK, Dahl O, Shivdasani RA, Tsao MS,
Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK and
Meyerson M: SOX2 is an amplified lineage-survival oncogene in lung
and esophageal squamous cell carcinomas. Nat Genet. 41:1238–1242.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yuan P, Kadara H, Behrens C, Tang X, Woods
D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E,
Xie Y, Girard L, Moran C, Hong WK, Minna JD and Wistuba II: Sex
determining region Y-Box 2 (SOX2) is a potential cell-lineage gene
highly expressed in the pathogenesis of squamous cell carcinomas of
the lung. PLoS One. 5:e91122010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hussenet T, Dali S, Exinger J, Monga B,
Jost B, Dembele D, Martinet N, Thibault C, Huelsken J, Brambilla E
and du Manoir S: SOX2 is an oncogene activated by recurrent 3q26.3
amplifications in human lung squamous cell carcinomas. PLoS One.
5:e89602010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Freier K, Knoepfle K, Flechtenmacher C,
Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P and
Radlwimmer B: Recurrent copy number gain of transcription factor
SOX2 and corresponding high protein expression in oral squamous
cell carcinoma. Genes Chromosomes Cancer. 49:9–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Maier S, Wilbertz T, Braun M, Scheble V,
Reischl M, Mikut R, Menon R, Nikolov P, Petersen K, Beschorner C,
Moch H, Kakies C, Protzel C, Bauer J, Soltermann A, Fend F,
Staebler A, Lengerke C and Perner S: SOX2 amplification is a common
event in squamous cell carcinomas of different organ sites. Hum
Pathol. 42:1078–1088. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wilbertz T, Wagner P, Petersen K, Stiedl
AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H,
Fend F, Staebler A, Bass AJ, Meyerson M, Rubin MA, Soltermann A,
Lengerke C and Perner S: SOX2 gene amplification and protein
overexpression are associated with better outcome in squamous cell
lung cancer. Mod Pathol. 24:944–953. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Li J, Pan G, Cui K, Liu Y, Xu S and Pei D:
A dominant-negative form of mouse SOX2 induces trophectoderm
differentiation and progressive polyploidy in mouse embryonic stem
cells. J Biol Chem. 282:19481–19492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Liu K, Lin B, Zhao M, Yang X, Chen M, Gao
A, Liu F, Que J and Lan X: The multiple roles for Sox2 in stem cell
maintenance and tumorigenesis. Cell Signal. 25:1264–1271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dhodapkar MV and Dhodapkar KM: Spontaneous
and therapy-induced immunity to pluripotency genes in humans:
clinical implications, opportunities and challenges. Cancer Immunol
Immunother. 60:413–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Smahel M, Sima P, Ludvikova V and Vonka V:
Modified HPV16 E7 genes as DNA vaccine against E7-containing
oncogenic cells. Virology. 281:231–238. 2001. View Article : Google Scholar
|
|
23.
|
Alexander J, Sidney J, Southwood S,
Ruppert J, Oseroff C, Maewal A, Snoke K, Serra HM, Kubo RT and
Sette A: Development of high potency universal DR-restricted helper
epitopes by modification of high affinity DR-blocking peptides.
Immunity. 1:751–761. 1994. View Article : Google Scholar
|
|
24.
|
Jainchill JL, Aaronson SA and Todaro GJ:
Murine sarcoma and leukemia viruses: assay using clonal lines of
contact-inhibited mouse cells. J Virol. 4:549–553. 1969.PubMed/NCBI
|
|
25.
|
Lin KY, Guarnieri FG, Staveley OK,
Levitsky HI, August JT, Pardoll DM and Wu TC: Treatment of
established tumors with a novel vaccine that enhances major
histocompatibility class II presentation of tumor antigen. Cancer
Res. 56:21–26. 1996.PubMed/NCBI
|
|
26.
|
Smahel M, Smahelova J, Tejklova P, Tachezy
R and Marinov I: Characterization of cell lines derived from tumors
induced by TC-1 cells in mice preimmunized against HPV16 E7
oncoprotein. Int J Oncol. 27:731–742. 2005.PubMed/NCBI
|
|
27.
|
Kaufmann AM, Gissmann L, Schreckenberger C
and Qiao L: Cervical carcinoma cells transfected with the CD80 gene
elicit a primary cytotoxic T lymphocyte response specific for HPV
16 E7 antigens. Cancer Gene Ther. 4:377–382. 1997.
|
|
28.
|
Sudbeck P and Scherer G: Two independent
nuclear localization signals are present in the DNA-binding
high-mobility group domains of SRY and SOX9. J Biol Chem.
272:27848–27852. 1997. View Article : Google Scholar
|
|
29.
|
Smahel M, Sima P, Ludvikova V, Marinov I,
Pokorna D and Vonka V: Immunisation with modified HPV16 E7 genes
against mouse oncogenic TC-1 cell sublines with downregulated
expression of MHC class I molecules. Vaccine. 21:1125–1136. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Fath S, Bauer AP, Liss M, Spriestersbach
A, Maertens B, Hahn P, Ludwig C, Schafer F, Graf M and Wagner R:
Multiparameter RNA and codon optimization: a standardized tool to
assess and enhance autologous mammalian gene expression. PLoS One.
6:e175962011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Smahel M, Polakova I, Duskova M, Ludvikova
V and Kastankova I: The effect of helper epitopes and cellular
localization of an antigen on the outcome of gene gun DNA
immunization. Gene Ther. 21:225–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Furuichi Y, Tokuyama H, Ueha S, Kurachi M,
Moriyasu F and Kakimi K: Depletion of
CD25+CD4+T cells (Tregs) enhances the
HBV-specific CD8+ T cell response primed by DNA
immunization. World J Gastroenterol. 11:3772–3777. 2005.PubMed/NCBI
|
|
33.
|
Chuang CM, Hoory T, Monie A, Wu A, Wang MC
and Hung CF: Enhancing therapeutic HPV DNA vaccine potency through
depletion of CD4+CD25+ T regulatory cells.
Vaccine. 27:684–689. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Jacob JB, Kong YC, Nalbantoglu I, Snower
DP and Wei WZ: Tumor regression following DNA vaccination and
regulatory T cell depletion in neu transgenic mice leads to an
increased risk for autoimmunity. J Immunol. 182:5873–5881. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Dhodapkar KM, Gettinger SN, Das R,
Zebroski H and Dhodapkar MV: SOX2-specific adaptive immunity and
response to immunotherapy in non-small cell lung cancer.
Oncoimmunology. 2:e252052013. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Noh KH, Lee YH, Jeon JH, Kang TH, Mao CP,
Wu TC and Kim TW: Cancer vaccination drives Nanog-dependent
evolution of tumor cells toward an immune-resistant and stem-like
phenotype. Cancer Res. 72:1717–1727. 2012. View Article : Google Scholar
|
|
37.
|
Whiteside TL: Regulatory T cell subsets in
human cancer: are they regulating for or against tumor progression?
Cancer Immunol Immunother. 63:67–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
